Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 393

1.

Outrageous prices of orphan drugs: a call for collaboration.

Luzzatto L, Hyry HI, Schieppati A, Costa E, Simoens S, Schaefer F, Roos JCP, Merlini G, Kääriäinen H, Garattini S, Hollak CE, Remuzzi G; Second Workshop on Orphan Drugs participants.

Lancet. 2018 Sep 1;392(10149):791-794. doi: 10.1016/S0140-6736(18)31069-9. Epub 2018 Jul 20. No abstract available.

PMID:
30037734
2.

Limited Exchange Transfusion Can Be Very Beneficial in Sickle Cell Anemia with Acute Chest Syndrome: A Case Report from Tanzania.

Chamba C, Iddy H, Tebuka E, Tluway F, Osati E, Budodi N, Meda C, Yonazi M, Schuh A, Luzzatto L, Makani J.

Case Rep Hematol. 2018 Jun 21;2018:5253625. doi: 10.1155/2018/5253625. eCollection 2018.

3.

Genes expressed in red cells could shape a malaria attack.

Luzzatto L.

Lancet Haematol. 2018 Aug;5(8):e322-e323. doi: 10.1016/S2352-3026(18)30110-8. Epub 2018 Jul 20. No abstract available.

4.

Advances in understanding the pathogenesis of acquired aplastic anaemia.

Luzzatto L, Risitano AM.

Br J Haematol. 2018 Sep;182(6):758-776. doi: 10.1111/bjh.15443. Epub 2018 Jul 5. Review.

PMID:
29974931
5.

Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.

Luzzatto L, Arese P.

N Engl J Med. 2018 Mar 15;378(11):1068-1069. doi: 10.1056/NEJMc1801271. No abstract available.

6.

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.

Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L.

Malar J. 2018 Mar 2;17(1):101. doi: 10.1186/s12936-018-2248-y. Review.

7.

The "escape" model: a versatile mechanism for clonal expansion.

Luzzatto L, Notaro R.

Br J Haematol. 2018 Jan 24. doi: 10.1111/bjh.15111. [Epub ahead of print] No abstract available.

PMID:
29363740
8.

Sterile 'Abscess' of the Spleen and the Sickle Cell Trait.

Luzzatto L.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018003. doi: 10.4084/MJHID.2018.003. eCollection 2018. No abstract available.

9.

Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.

Luzzatto L, Arese P.

N Engl J Med. 2018 Jan 4;378(1):60-71. Review. No abstract available.

PMID:
29298156
10.

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, De Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, Van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P.

ESMO Open. 2017 Jan 6;1(6):e000127. doi: 10.1136/esmoopen-2016-000127. eCollection 2016. Review.

11.

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.

Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, Möhrle JJ, Rousell V, Mohamed K, Qureshi A, Narayan S, Yubon N, Miller A, Nosten FH, Luzzatto L, Duparc S, Kleim JP, Green JA.

Am J Trop Med Hyg. 2017 Sep;97(3):702-711. doi: 10.4269/ajtmh.16-0779. Epub 2017 Jul 27.

12.

Glycosylphosphatidylinositol-specific T cells, IFN-γ-producing T cells, and pathogenesis of idiopathic aplastic anemia.

Gargiulo L, Zaimoku Y, Scappini B, Maruyama H, Ohumi R, Luzzatto L, Nakao S, Notaro R.

Blood. 2017 Jan 19;129(3):388-392. doi: 10.1182/blood-2016-09-740845. Epub 2016 Nov 30. No abstract available.

13.

Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.

Reading NS, Sirdah MM, Shubair ME, Nelson BE, Al-Kahlout MS, Al-Tayeb JM, Aboud LN, Shaban MA, Luzzatto L, Prchal JT.

Blood Cells Mol Dis. 2016 Sep;60:58-64. doi: 10.1016/j.bcmd.2016.07.001. Epub 2016 Jul 6.

PMID:
27519946
14.

Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations.

Montagnani V, Benelli M, Apollo A, Pescucci C, Licastro D, Urso C, Gerlini G, Borgognoni L, Luzzatto L, Stecca B.

Oncotarget. 2016 May 24;7(21):30365-78. doi: 10.18632/oncotarget.8758.

15.

Glucose-6-Phosphate Dehydrogenase Deficiency.

Luzzatto L, Nannelli C, Notaro R.

Hematol Oncol Clin North Am. 2016 Apr;30(2):373-93. doi: 10.1016/j.hoc.2015.11.006. Review.

PMID:
27040960
16.

Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria.

Luzzatto L.

F1000Res. 2016 Feb 23;5. pii: F1000 Faculty Rev-209. doi: 10.12688/f1000research.7288.1. eCollection 2016. Review.

17.

G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria.

Luzzatto L.

Lancet Haematol. 2015 Oct;2(10):e400-1. doi: 10.1016/S2352-3026(15)00191-X. Epub 2015 Sep 22. No abstract available.

18.

[Oncogenesis: theories and facts].

Luzzatto L.

Epidemiol Prev. 2015 Jul-Aug;39(4):218-9. Italian. No abstract available.

PMID:
26499232
19.

Causality and Chance in the Development of Cancer.

Luzzatto L, Pandolfi PP.

N Engl J Med. 2015 Oct 15;373(16):1579. doi: 10.1056/NEJMc1509651. No abstract available.

20.

Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry.

Cetica V, Sieni E, Pende D, Danesino C, De Fusco C, Locatelli F, Micalizzi C, Putti MC, Biondi A, Fagioli F, Moretta L, Griffiths GM, Luzzatto L, Aricò M.

J Allergy Clin Immunol. 2016 Jan;137(1):188-196.e4. doi: 10.1016/j.jaci.2015.06.048. Epub 2015 Sep 2.

21.

Cutaneous tissue expressions of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 are associated with a high degree of disability at diagnosis of hanseniasis.

Teixeira KA, Garbin G, Luzzatto L, Eidt LM, Bonamigo RR.

Int J Dermatol. 2015 Sep;54(9):e361-2. doi: 10.1111/ijd.12678. Epub 2015 Jul 23. No abstract available.

PMID:
26206413
22.

Causality and Chance in the Development of Cancer.

Luzzatto L, Pandolfi PP.

N Engl J Med. 2015 Jul 2;373(1):84-8. doi: 10.1056/NEJMsb1502456. No abstract available.

PMID:
26132946
23.

[Causality and chance in oncogenesis].

Luzzatto L.

Epidemiol Prev. 2015 Jan-Feb;39(1):3-4. Italian. No abstract available.

PMID:
26030941
24.

Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria.

Olutogun T, Cutini I, Notaro R, Luzzatto L.

Blood Transfus. 2015 Jul;13(3):363-9. doi: 10.2450/2015.0249-14. Epub 2015 Feb 2. Review. No abstract available.

25.

Rare diseases and effective treatments: are we delivering?

Luzzatto L, Hollak CE, Cox TM, Schieppati A, Licht C, Kääriäinen H, Merlini G, Schaefer F, Simoens S, Pani L, Garattini S, Remuzzi G.

Lancet. 2015 Feb 28;385(9970):750-2. doi: 10.1016/S0140-6736(15)60297-5. No abstract available.

PMID:
25752159
26.

SETIL: Italian multicentric epidemiological case-control study on risk factors for childhood leukaemia, non hodgkin lymphoma and neuroblastoma: study population and prevalence of risk factors in Italy.

Magnani C, Mattioli S, Miligi L, Ranucci A, Rondelli R, Salvan A, Bisanti L, Masera G, Rizzari C, Zambon P, Cannizzaro S, Gafà L, Luzzatto LL, Benvenuti A, Michelozzi P, Kirchmayer U, Cocco P, Biddau P, Galassi C, Celentano E, Guarino E, Assennato G, de Nichilo G, Merlo DF, Bocchini V, Pannelli F, Mosciatti P, Minelli L, Chiavarini M, Cuttini M, Casotto V, Torregrossa MV, Valenti RM, Forastiere F, Haupt R, Lagorio S, Risica S, Polichetti A.

Ital J Pediatr. 2014 Dec 24;40:103. doi: 10.1186/s13052-014-0103-5.

27.

Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis.

Williams CK, Foroni L, Luzzatto L, Saliu I, Levine A, Greaves MF.

Ecancermedicalscience. 2014 Nov 6;8:478. doi: 10.3332/ecancer.2014.478. eCollection 2014.

28.

Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells.

Makarona K, Caputo VS, Costa JR, Liu B, O'Connor D, Iskander D, Roper D, Robertson L, Bhatnagar N, Terpos E, Georgiou E, Papaioannou M, Layton DM, Luzzatto L, Roberts I, Karadimitris A.

Blood. 2014 Jul 3;124(1):134-41. doi: 10.1182/blood-2014-02-553792. Epub 2014 May 7.

29.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

Relling MV, McDonagh EM, Chang T, Caudle KE, McLeod HL, Haidar CE, Klein T, Luzzatto L; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2014 Aug;96(2):169-74. doi: 10.1038/clpt.2014.97. Epub 2014 May 2.

30.

Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria.

Araten DJ, Iori AP, Brown K, Torelli GF, Barberi W, Natalino F, De Propris MS, Girmenia C, Salvatori FM, Zelig O, Foà R, Luzzatto L.

J Hematol Oncol. 2014 Mar 27;7:27. doi: 10.1186/1756-8722-7-27.

31.

Resistance to "castration-resistant".

Luzzatto L.

Oncologist. 2014 Mar;19(3):305. doi: 10.1634/theoncologist.2013-0363. Epub 2014 Feb 17. No abstract available.

32.

G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.

Luzzatto L, Seneca E.

Br J Haematol. 2014 Feb;164(4):469-80. doi: 10.1111/bjh.12665. Epub 2013 Dec 28. Review.

33.

Congenital agminated melanocytic nevus--case report.

Rocha CR, Grazziotin TC, Rey MC, Luzzatto L, Bonamigo RR.

An Bras Dermatol. 2013 Nov-Dec;88(6 Suppl 1):170-2. doi: 10.1590/abd1806-4841.20132137.

34.

Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Rondelli T, Risitano AM, Peffault de Latour R, Sica M, Peruzzi B, Ricci P, Barcellini W, Iori AP, Boschetti C, Valle V, Frémeaux-Bacchi V, De Angioletti M, Socie G, Luzzatto L, Notaro R.

Haematologica. 2014 Feb;99(2):262-6. doi: 10.3324/haematol.2013.090001. Epub 2013 Sep 13.

35.

PNH from mutations of another PIG gene.

Luzzatto L.

Blood. 2013 Aug 15;122(7):1099-100. doi: 10.1182/blood-2013-06-508556.

36.

Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria.

Gargiulo L, Papaioannou M, Sica M, Talini G, Chaidos A, Richichi B, Nikolaev AV, Nativi C, Layton M, de la Fuente J, Roberts I, Luzzatto L, Notaro R, Karadimitris A.

Blood. 2013 Apr 4;121(14):2753-61. doi: 10.1182/blood-2012-11-469353. Epub 2013 Jan 31.

37.

The frequency of granulocytes with spontaneous somatic mutations: a wide distribution in a normal human population.

Rondelli T, Berardi M, Peruzzi B, Boni L, Caporale R, Dolara P, Notaro R, Luzzatto L.

PLoS One. 2013;8(1):e54046. doi: 10.1371/journal.pone.0054046. Epub 2013 Jan 14.

38.

A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.

Mannelli F, Bencini S, Peruzzi B, Cutini I, Sanna A, Benelli M, Magi A, Gianfaldoni G, Rotunno G, Carrai V, Gelli AM, Valle V, Santini V, Notaro R, Luzzatto L, Bosi A.

Cytometry B Clin Cytom. 2013 Mar;84(2):71-81. doi: 10.1002/cyto.b.21064. Epub 2012 Dec 26.

39.

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.

White NJ, Qiao LG, Qi G, Luzzatto L.

Malar J. 2012 Dec 14;11:418. doi: 10.1186/1475-2875-11-418. Review.

40.

Sickle cell anaemia and malaria.

Luzzatto L.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012065. doi: 10.4084/MJHID.2012.065. Epub 2012 Oct 3.

41.

Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.

Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono AB, Luzzatto L.

Blood. 2012 Nov 15;120(20):4123-33. doi: 10.1182/blood-2012-03-416032. Epub 2012 Sep 19.

42.

The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.

Marchini S, Poynor E, Barakat RR, Clivio L, Cinquini M, Fruscio R, Porcu L, Bussani C, D'Incalci M, Erba E, Romano M, Cattoretti G, Katsaros D, Koff A, Luzzatto L.

Clin Cancer Res. 2012 Aug 15;18(16):4313-24. Epub 2012 Jun 25.

43.

Feasibility of evaluating quality cancer care using registry data and electronic health records: a population-based study.

Caldarella A, Amunni G, Angiolini C, Crocetti E, Di Costanzo F, Di Leo A, Giusti F, Pegna AL, Mantellini P, Luzzatto L, Paci E.

Int J Qual Health Care. 2012 Aug;24(4):411-8. doi: 10.1093/intqhc/mzs020. Epub 2012 May 16.

PMID:
22597705
44.

The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment.

Risitano AM, Notaro R, Pascariello C, Sica M, del Vecchio L, Horvath CJ, Fridkis-Hareli M, Selleri C, Lindorfer MA, Taylor RP, Luzzatto L, Holers VM.

Blood. 2012 Jun 28;119(26):6307-16. doi: 10.1182/blood-2011-12-398792. Epub 2012 May 10.

45.

Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.

Araten DJ, Notaro R, Thaler HT, Kernan N, Boulad F, Castro-Malaspina H, Small T, Scaradavou A, Magnan H, Prockop S, Chaffee S, Gonsky J, Thertulien R, Tarquini R, Luzzatto L.

Haematologica. 2012 Mar;97(3):344-52. doi: 10.3324/haematol.2011.049767. Epub 2011 Dec 1. Review.

46.

G6PD deficiency and malaria selection.

Luzzatto L.

Heredity (Edinb). 2012 Apr;108(4):456. doi: 10.1038/hdy.2011.90. Epub 2011 Oct 19. No abstract available.

47.

Crusted rosacea-like demodicidosis in an HIV-positive female.

Brutti CS, Artus G, Luzzatto L, Bonamigo RR, Balconi SN, Vettorato R.

J Am Acad Dermatol. 2011 Oct;65(4):e131-e132. doi: 10.1016/j.jaad.2011.05.037. No abstract available.

PMID:
21920237
48.

Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population.

Russo R, Gambale A, Esposito MR, Serra ML, Troiano A, De Maggio I, Capasso M, Luzzatto L, Delaunay J, Tamary H, Iolascon A.

Am J Hematol. 2011 Sep;86(9):727-32. doi: 10.1002/ajh.22096.

49.

A Role for PML in Innate Immunity.

Lunardi A, Gaboli M, Giorgio M, Rivi R, Bygrave A, Antoniou M, Drabek D, Dzierzak E, Fagioli M, Salmena L, Botto M, Cordon-Cardo C, Luzzatto L, Pelicci PG, Grosveld F, Pandolfi PP.

Genes Cancer. 2011 Jan;2(1):10-9. doi: 10.1177/1947601911402682.

50.

Haematology in Africa.

Luzzatto L, Fasola F, Tshilolo L.

Br J Haematol. 2011 Sep;154(6):777-82. doi: 10.1111/j.1365-2141.2011.08763.x. Epub 2011 Jul 5. No abstract available.

Supplemental Content

Loading ...
Support Center